Press Releases

Press Releases

ICYMI: David Mitchell Named One of Washington’s Most Influential People for Third Year in a Row

WASHINGTON, D.C. — Patients For Affordable Drugs’ founder and president, David Mitchell, has once again been included in Washingtonian’s Washington DC’s 500 Most Influential People of 2025. This marks the third consecutive year David has been recognized for his tireless work to lower prescription drug prices for patients across the country. “David’s relentless commitment to reforming the drug […]

Press Releases

Patients For Affordable Drugs Sends Open Letter To Patient Community on the 100th Day of the Trump Administration

To our Community, Today marks one hundred days into the new presidential administration. A key moment to take stock and reflect on where we are in the fight to lower drug prices for all Americans. Over the past several weeks, we’ve heard directly from nearly 1,000 people in our community – patients, family members, caregivers […]

Press Releases

ICYMI: New Poll Shows Overwhelming Support for Medicare Drug Price Negotiation — and Republicans are Taking Note

Voters — including a majority of Trump supporters — demand action to lower drug prices as Big Pharma’s favorability plummets. WASHINGTON, D.C. — A new poll released last week, conducted by Trump pollster Fabrizio Ward and commissioned by Arnold Ventures, reveals just how potent the issue of prescription drug pricing has become, not just with voters overall, but with an overwhelming […]

Press Releases

STATEMENT: Patients For Affordable Drugs Responds To President Trump’s Executive Order On Prescription Drug Prices

WASHINGTON, D.C. — In response to President Trump’s new executive order on prescription drug prices, Merith Basey, Executive Director of Patients For Affordable Drugs, issued the following statement: “This executive order (EO) signals that the Administration recognizes the urgency of tackling high drug prices, in line with what the majority of Americans are demanding. The first round […]

Press Releases

RELEASE: Patients For Affordable Drugs Launches New Ad on Fox & Friends Encouraging Pres. Trump to Negotiate A Better Deal for American Patients

WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) has launched a new TV ad set to air nationally on Fox & Friends today. The ad encourages President Donald Trump to continue protecting Medicare’s ability to negotiate lower drug prices – a policy his Administration has defended in court and one that will save patients and taxpayers […]

Press Releases

RELEASE: All 12 Drug Manufacturers Agree To Participate In Second Round Of Medicare Negotiations

Patients For Affordable Drugs Welcomes Key Milestone While Holding Drug Companies Accountable For Ongoing Legal Attacks WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) announced Friday that all 12 manufacturers of the 15 drugs selected for the second round of the Medicare negotiation program voluntarily agreed to participate. While this is another critical step […]

Press Releases

Patients For Affordable Drugs Files Fourth Patient-Focused Amicus Brief, Defending The Historic Drug Pricing Law Against Attacks By Big Pharma

WASHINGTON, D.C. — Today, Patients For Affordable Drugs (P4AD) filed an amicus brief in the U.S. Court of Appeals for the Third Circuit, defending Medicare’s ability to negotiate lower drug prices against a lawsuit brought by pharmaceutical giant Novartis. The lawsuit is part of a broader industry-wide legal assault aimed at dismantling the 2022 prescription drug law’s historic […]

Press Releases

STATEMENT: Patients For Affordable Drugs Responds To Confirmation Of Robert F. Kennedy Jr. As HHS Secretary

WASHINGTON, D.C. — Following a narrow Senate vote, Robert F. Kennedy Jr., was confirmed today as Secretary of the Department of Health and Human Services (HHS). P4AD Executive Director, Merith Basey, released the following statement: “Secretary Kennedy has a critical opportunity – and responsibility – to build on existing measures to rein in Big Pharma’s price-gouging and lower drug […]